pubmed-article:19569249 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C0026986 | lld:lifeskim |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C0010802 | lld:lifeskim |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C0348026 | lld:lifeskim |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C0086345 | lld:lifeskim |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C0079611 | lld:lifeskim |
pubmed-article:19569249 | lifeskim:mentions | umls-concept:C1880156 | lld:lifeskim |
pubmed-article:19569249 | pubmed:issue | 19 | lld:pubmed |
pubmed-article:19569249 | pubmed:dateCreated | 2009-9-23 | lld:pubmed |
pubmed-article:19569249 | pubmed:abstractText | Because of limited reproducibility of morphologic features, the morphological categorization of initial myelodysplastic syndromes (MDS) cases remains a major task in a diagnostic setting. | lld:pubmed |
pubmed-article:19569249 | pubmed:language | eng | lld:pubmed |
pubmed-article:19569249 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19569249 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19569249 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19569249 | pubmed:month | Oct | lld:pubmed |
pubmed-article:19569249 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:SchnittgerSus... | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:HaferlachTors... | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:KernWolfgangW | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:BacherUlrikeU | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:HaferlachClau... | lld:pubmed |
pubmed-article:19569249 | pubmed:author | pubmed-author:WeissTamaraT | lld:pubmed |
pubmed-article:19569249 | pubmed:copyrightInfo | 2009 American Cancer Society. | lld:pubmed |
pubmed-article:19569249 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19569249 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19569249 | pubmed:volume | 115 | lld:pubmed |
pubmed-article:19569249 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19569249 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19569249 | pubmed:pagination | 4524-32 | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:meshHeading | pubmed-meshheading:19569249... | lld:pubmed |
pubmed-article:19569249 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19569249 | pubmed:articleTitle | The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes. | lld:pubmed |
pubmed-article:19569249 | pubmed:affiliation | Department of Stem Cell Transplantation, University Cancer Center Hamburg, Hamburg, Germany. | lld:pubmed |
pubmed-article:19569249 | pubmed:publicationType | Journal Article | lld:pubmed |